CoatesAS, AbrahamS, KayeSB, . On the receiving end: Patient perceptions of the side effects of cancer chemotherapy. Eur J Cancer Clin Oncol1983; 19: 203–208.
2.
AitkenRCB. Measurement of feelings using visual analogue scales. Proc Roy Soc Med1969; 62:989–996.
3.
PriestmanTJ, BaumM.Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet1976; 1:899–901.
4.
PriestmanTJ, BaumM, JonesV, ForbesJ.Comparative trial of endocrine versus cytotoxic treatment in advanced breast cancer. Br Med J1977; 1:1248–1250.
5.
CoatesAS, FischerDillenbeck C, McNeilDR, KayeSB, SimsK, FoxRM, HedleyD, RaghavanD, WoodsRL, MiltonGW, TattersallMHN. On the receiving end, II: Linear analogue self assessment in the evaluation of quality of life of cancer patients. Eur J Cancer Clin Oncol1983; 19:1633–1638.
6.
JaeschkeR, SingerJ, GuyattGH. A comparison of seven-point and visual analogue scales. Data from a randomized trial. Controlled Clin Trials1990; 11:43–51.
7.
CoatesAS, GlasziouP, McNeilD.On the receiving end, III: Measurement of quality of life during cancer chemotherapy. Ann Oncol1990; 1: 213–217.
8.
DonovanK, Sanson-FisherRW, RedmanS.Measuring quality of life in cancer patients. J Clin Oncol1989; 7:959–968.
9.
Australian New Zealand Breast Cancer Trials Group.A randomized trial in postmenopausal patients with advanced breast cancer comparing endocrine and cytotoxic therapy given sequentially or in combination. J Clin Oncol1986; 4:186–193.
10.
CoatesAS, GebskiV, BishopJF, JealPN, WoodsRL, SnyderR, TattersallMHN, ByrneM, HarveyV, GillG, SimpsonJ, DrummondR, BrowneJ, Van CootenR, ForbesJF, for the Australian New Zealand Breast Cancer Trials Group. Improving the quality of life during chemotherapy for advanced breast cancer: A comparison of intermittent and continuous treatment strategies. N Engl J Med1987; 317:1490–1495.
11.
SpitzerWO, DobsonAJ, HallJ, ChestermanE, LeviJ, ShepherdR, BattistaRN, CatchloveBR. Measuring the quality of life of cancer patients: A concise QL index for use by physicians. J Chron Dis1981; 34:585–597.
12.
CoatesAS, ByrneM, BishopJF, ForbesJF. Intermittent versus continuous chemotherapy for breast cancer (letter). N Engl J Med1988, 318, 1468.
13.
TannockIF, BoydN, DeBoerG, . A randomized trial of two dose levels of cyclophosphamide, methotrexate and fluorouracil chemotherapy for patients with metastatic breast cancer. J Clin Oncol1988; 6:1377–1387.
14.
CoatesAS, GebskiV, SignoriniD, MurrayP, McNeilDR, ByrneM, ForbesJ, for the Australian New Zealand Breast Cancer Trials Group. Prognostic value of quality of life scores during chemotherapy for advanced breast cancer. J Clin Oncol1992 (in press).
15.
ButowP, CoatesAS, DunnS, BernhardJ, HurnyC.On the receiving end, IV: Validation of quality of life indicators. Ann Oncol1991; 2:597–603.
16.
HurnyC, BernhardJ, GelberRD, CoatesAS, CastiglioneM, IsleyM, DreherD, PetersonH, GoldhirschA, SennHJ, for the International Breast Cancer Study Group. Quality of life measures for patients receiving adjuvant therapy for breast cancer: An international trial. Eur J Cancer1992; 28:118–124.
17.
ZerssenDV. Clinical self-rating scales (CSRS) of the Munich Psychiatric Information System (PSYCHIS Munchen). In SartoriusN, BanTA (eds). Assessment of Depression. Berlin: Springer, 1986, pp 270–303.
18.
SchipperH, ClinchJ, McMurrayA. Measuring the quality of life of cancer patients: The Functional Living Index — Cancer: Development and validation. J Clin Oncol1984; 2:472–483.
19.
ZigmundAS, SnaithRP. The Hospital Anxiety and Depression Scale. Acta Psych Scand1983; 67:362–370.
20.
McNairDM. EITS Manual for the Profile of Mood States. San Diego: EITS, 1981.
21.
MillerAB, HoogstraatenB, StaquetM, WinklerA.Reporting results of cancer treatment. Cancer1981; 47:207–214.
